Dry Needling and Muscle Stiffness

Sponsor
University of British Columbia (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05538598
Collaborator
(none)
28
1
12

Study Details

Study Description

Brief Summary

The goal of this study is to investigate the effect of intramuscular dry needling (IMDN) on muscle stiffness and pain. Research has suggested that IMDN can reduce muscle stiffness in needled areas. As well, IMDN may reduce mechanical pain sensitivity experienced by individuals.

IMDN will be performed at several anatomical locations. Muscle stiffness will be measured with a handheld probe, which measures contact force and displacement of soft tissue. Pressure-pain thresholds (PPT) will be discovered at each region of interest. Stiffness and pressure-pain thresholds will be collected before and after IMDN. The data collected from this research is important to understand the mechanism of IMDN and its relationship to pain.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Intramuscular Dry Needling
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
28 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
Repeated measures design with pre-post measuresRepeated measures design with pre-post measures
Masking:
None (Open Label)
Primary Purpose:
Basic Science
Official Title:
Effect of Intramuscular Dry Needling on Soft Tissue Stiffness and Pressure-pain Thresholds
Anticipated Study Start Date :
Sep 1, 2022
Anticipated Primary Completion Date :
Sep 1, 2023
Anticipated Study Completion Date :
Sep 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intramuscular Dry Needling

IMDN will be performed at the sacral multifidus and fibularis longus muscles.

Procedure: Intramuscular Dry Needling
The insertion of thin monofilament needles (without injectate) into a tight band of muscle. The needles will be inserted into the muscle for ~10 seconds.

Outcome Measures

Primary Outcome Measures

  1. Effective stiffness of soft tissue [Within 10 minutes of intervention]

    Force-displacement data is collected while deforming the soft tissue at the skin surface with a non-invasive handheld probe. The effective stiffness is a summary of the deformation behavior of the soft tissue. It is estimated using the force-displacement data as an input to the incompressible isotropic hyperelastic Ogden model. A higher value indicates that the soft tissue is stiffer than a lower value.

  2. Pressure-pain threshold [Within 10 minutes of intervention]

    The measured pressure at the moment the perception of pressure turns into pain

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • over the age of 18

  • pain-free in your lower back and lower legs

Exclusion Criteria:
  • unable to communicate in English

  • surgery of any kind in the lumbar spine or lower legs.

  • participants with a skin condition that does not allow for hypoallergenic tape to be attached to their skin.

  • have a BMI>25

  • unable to hold your breath for 20 seconds

  • contraindications to dry needling, i.e. pregnancy; fever or infection that is in your bloodstream; unstable compromised immune system; unstable bleeding disorders; presence at the site of DN of infection, an open wound , a burn, cellulitis, or an undiagnosed lump; post- mastectomy/lymph node removal in the affected limb; post-major surgery (3-6 month time period); presence of metal or plastic implant; absent sensation in area of planned DN; post-bacterial endocarditis or heart valve conditions/replacement without medical clearance for DN from medical doctor.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • University of British Columbia

Investigators

  • Principal Investigator: Michael Koehle, MD, PhD, University of British Columbia

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Michael Koehle, Principal Investigator, University of British Columbia
ClinicalTrials.gov Identifier:
NCT05538598
Other Study ID Numbers:
  • H22-01852
First Posted:
Sep 14, 2022
Last Update Posted:
Sep 14, 2022
Last Verified:
Sep 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Sep 14, 2022